GW researchers successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, affecting more than a quarter of a billion people in Southeast Asia, sub-Saharan Africa, and Latin America
For the first time, researchers at the George Washington University (GW), together with colleagues at institutes in Thailand, Australia, the U.K. and the Netherlands, and more, have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which can cause a diverse spectrum of human disease including bile duct cancer. Their findings are found in two papers published today in the journal eLife.
“The genes we ‘knocked out’ using CRISPR/Cas9 resulted in markedly diminished symptoms of infection in our animal models,” said Paul Brindley, PhD, professor of microbiology, immunology, and tropical medicine at the GW School of Medicine and Health Sciences, and lead author. “Our research also showed that this revolutionary new biomedical procedure — CRISPR/Cas9 — can be adapted to study helminth parasites, which are a major public health problem in tropical climates.”
CRISPR/Cas9 is a new technology that allows researchers to precisely target and deactivate the genetic information needed to produce a particular protein. While the tool has been used in other species before, it was unknown if it could be applied to Schistosoma mansoni and Opisthorchis viverrini, the parasites responsible for schistosomiasis and liver fluke infection.
Schistosomiasis can cause serious health problems, including damage to the liver and kidneys, infertility and bladder cancer. The freshwater worms S. mansoni enter the human body by burrowing into the skin; once in the bloodstream, they move to various organs where they rapidly start to reproduce. Their eggs release several molecules, including a protein known as omega-1 ribonuclease, which can damage the surrounding tissues. Brindley and his research team “knocked out” this protein using CRISPR/Cas9 and found that it greatly reduced the impact of the disease.
Liver fluke infection can cause a type of liver cancer called bile duct cancer, triggered by the presence of the worm O. viverrini. This parasite is transmitted through traditional Southeast Asian cuisines using uncooked or undercooked fish. Once inside the body, the parasite settles in the human liver and secretes a protein known as granulin that may encourage liver cells to multiply, raising the risk for cancer. Brindley and his research team used CRISPR/Cas9 to deactivate the gene that codes for granulin and create parasites that can only produce very little of the protein, leading to markedly reduced symptoms of liver fluke infection.
“These neglected tropical diseases affect more than a quarter of a billion people primarily living in Southeast Asia, sub-Saharan Africa, and Latin America,” said Brindley. “CRISPR/Cas9 is a tool that may be used to limit the impact of these infections. As we work to better understand how these parasites invade and damage our bodies through this new technology, we will find new ideas for treatment and disease control.”
The Latest on: CRISPR/Cas9
via Google News
The Latest on: CRISPR/Cas9
- Scientists treat first US patients with gene-edited cells on April 17, 2019 at 10:41 am
CRISPR-cas9, the powerful gene-editing tool, has been getting a bad reputation lately following last year’s shocking news of Chinese twins born with altered genomes. But done diligently and ethically, ... […]
- CRISPR Screens Identify New Glioblastoma Targets and Resistance Genes on April 17, 2019 at 7:00 am
Scientists in Canada have used CRISPR-Cas9 technology to identify potential new targets for glioblastoma (GBM), the most common type of primary brain tumor in adults. The approach used genome editing ... […]
- CRISPR can turn human cells into biocomputers on April 16, 2019 at 4:15 pm
Researchers have integrated two CRISPR-Cas9-based core processors into human cells, a step towards creating powerful biocomputers. Controlling gene expression through gene switches based on a model ... […]
- First U.S. Patients Treated With CRISPR As Gene-Editing Human Trials Get Underway on April 16, 2019 at 10:20 am
The powerful gene-editing technique called CRISPR has been in the news a lot. And not all the news has been good: A Chinese scientist stunned the world last year when he announced he had used CRISPR ... […]
- Engineering ‘Hairpins’ Increases CRISPR Accuracy on April 16, 2019 at 6:35 am
“But the solutions proposed thus far cannot be easily translated between different CRISPR systems.” CRISPR/Cas9 is a defense system that bacteria use to target and cleave the DNA of invading viruses. ... […]
- CRISPR-Cas3 Innovation Holds Promise for Disease Cures, Advancing Science on April 16, 2019 at 6:31 am
The new system, called CRISPR-Cas3, can efficiently erase long stretches of DNA from a targeted site in the human genome, a capability not easily attainable in more traditional CRISPR-Cas9 systems. ... […]
- CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Beta Thalassemia on April 16, 2019 at 5:00 am
In February 2019, CRISPR Therapeutics and Vertex announced that the first patient had been treated with CTX001 in a Phase 1/2 clinical study of patients with TDT, marking the first company-sponsored ... […]
- A biosynthetic dual-core cell computer on April 16, 2019 at 4:52 am
ETH researchers have integrated two CRISPR-Cas9-based core processors into human cells. This represents a huge step towards creating powerful biocomputers. Controlling gene expression through gene ... […]
- A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system on April 10, 2019 at 2:09 am
Therapies that target the function of immune cells have significant clinical efficacy in diseases such as cancer and autoimmunity. Although functional genomics has accelerated therapeutic target ... […]
- New DNA Editing Technique Outstrips CRISPR/Cas9 Many Times Over on April 8, 2019 at 10:25 pm
Researchers have developed a new tool for gene-editing that is being compared to a DNA “shredder” called CRISPR/Cas3, able to edit long sequences of DNA with programmable alterations. […]
via Bing News